Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Drug Discovery
Sort By
Newest First
1 / 10
1 / 10
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02
June 11, 2024
Nice Insight API Report
Small Molecule API Discovery and Development Trends
April Stanley, MS MBA
PAO-03-24-NI-01
March 21, 2024
Genomics
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-24-NI-03
January 30, 2024
Molecular Machines
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-24-NI-02
January 22, 2024
In Vitro Biology
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Solutions
PR-M10-23-04
October 17, 2023
3D Cell Culture
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.
Corning Life Sciences
PAO-09-23-CL-02
September 29, 2023
R&D
Integrating Digital Solutions to Streamline Biopharma Operations
Christian Olsen
Dotmatics
PAO-07-23-CL-06
July 17, 2023
Oncology
Addressing Cancer Therapy Resistance by Targeting Translational Regulation
Steve Worland, Ph.D.
eFFECTOR
PAO-06-23-CL-02
June 01, 2023
Generative AI
Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat
Petrina Kamya, Ph.D.
Insilico Medicine
PAO-04-23-CL-02
April 13, 2023
Targeted Protein Degradation
Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs
Henrik Daub, Ph.D.
NEOsphere Biotechnologies GmbH
PAO-03-23-CL-07
March 30, 2023
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
Gil Efron
Purple Biotech
PAO-03-23-CL-01
March 21, 2023
Digital Twin Technology
The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-23-NI-02
March 07, 2023
Therapeutic Candidate
CytoDyn Takes Steps towards a Brighter Future
Cyrus Arman, Ph.D.
CytoDyn
PAO-02-23-CL-04
February 06, 2023
Artificial Intelligence
Artificial Intelligence in Pharma, As Told by Artificial Intelligence
Pharma's Almanac
Pharma's Almanac
PAO-01-23-CL-02
January 13, 2023
Artificial Intelligence in Antibody Design
Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence
Sumana Sundaramurthy, Ph.D.
Sino Biological
PAO-11-022-CL-15
January 10, 2023
Three Benefits of Using In Silico Technologies for Drug Discovery
Kimberly Brunner
PA169
January 04, 2023
Synthetic Biology
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-022-NI-01
December 23, 2022
Computational Drug Design
Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery
Ronald Dorenbos, Ph.D.; Guido Lanza
Charles River Laboratories
PAO-11-022-CL-11-180
December 07, 2022
Big Data
Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-05
October 11, 2022
Transient Expression
Overcoming Limitations with Transient Protein Expression to Accelerate Development
Cenk Sumen, Ph.D.
MaxCyte
PAO-10-022-CL-02
October 11, 2022
